Companies / Edgewise Therapeutics, Inc. / Activity
Activity — Edgewise Therapeutics, Inc.
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | Edris Badreddin Director | Sell | Common Stock | $1.96M | -66K -77.03% | 19,820 0.02% of shares | medium |
| Mar 31, 2026 | Donovan Joanne M. Executive | Sell | Common Stock | $685.3K | -21K -68.98% | 9,597 <0.01% of shares | medium |
| Jan 21, 2026 | Edris Badreddin Director | Sell | Common Stock | $507.4K | -17K -14.17% | 104,365 0.10% of shares | medium |
| Jan 21, 2026 | Edris Badreddin Director | Sell | Common Stock | $403.0K | -14K -10.12% | 121,601 0.11% of shares | medium |
| Jan 21, 2026 | Edris Badreddin Director | Sell | Common Stock | $308.0K | -10K -10.81% | 86,297 0.08% of shares | medium |
| Mar 27, 2026 | Donovan Joanne M. Executive | Sell | Common Stock | $298.1K | -10K -37.08% | 16,332 0.02% of shares | medium |
| Jan 21, 2026 | Edris Badreddin Director | Sell | Common Stock | $223.9K | -8K -7.29% | 96,760 0.09% of shares | medium |
| Mar 27, 2026 | Donovan Joanne M. Executive | Sell | Common Stock | $208.6K | -7K -41.24% | 9,597 <0.01% of shares | medium |